Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Fraenkel: mTOR inhibition by rapamycin prevents β-cell adaptation to hyperglycemia and exacerbat.... (0.09 sec) 

mTOR inhibition by rapamycin prevents β-cell adaptation to hyperglycemia and exacerbates …

- diabetesjournals.org
M Fraenkel, M Ketzinel-Gilad, Y Ariav, O … - Diabetes, 2008 - Am Diabetes Assoc
RESULTS—Unexpectedly, rapamycin worsened hyperglycemia in diabetic P. obesus
without affecting glycemia in normoglycemic controls. There was a 10-fold
increase of serum insulin in diabetic P. obesus compared with controls; ...
Cited by 20 - Related articles - BL Direct - All 4 versions

Disruption of Tsc2 in pancreatic β cells induces β cell mass expansion and improved …

- pnas.org
L Rachdi, N Balcazar, F Osorio-Duque, L … - Proceedings of the National Academy of Sciences, 2008 - National Acad Sciences
Regulation of pancreatic β cell mass and function is a major determinant for
the development of diabetes. Growth factors and nutrients are important
regulators of β cell mass and function. The signaling pathways by which ...
Cited by 12 - Related articles - All 6 versions

The role of mTOR in the adaptation and failure of β-cells in type 2 diabetes


G Leibowitz, E Cerasi, M Ketzinel-Gilad - Diabetes, Obesity and Metabolism, 2008 - interscience.wiley.com
Mammalian target of rapamycin (mTOR) is an important nutrient sensor that plays
a critical role in cellular metabolism, growth, proliferation and apoptosis and
in the cellular response to oxidative stress. In addition, mTOR–raptor ...
Cited by 4 - Related articles - All 3 versions

Chronic inhibition of mammalian target of rapamycin signaling downregulates insulin …

- asnjournals.org
S Di Paolo, A Teutonico, D Leogrande, C … - Journal of the American Society of Nephrology, 2006 - Am Soc Nephrol
Overactivation of the mammalian target of rapamycin (mTOR) branch downstream of
the phosphatidylinositol 3-kinase–AKT pathway critically modulates insulin and
growth factor signaling by insulin receptor substrates (IRS). On the basis ...
Cited by 23 - Related articles - All 6 versions

Psammomys obesus, a model for environment-gene interactions in type 2 diabetes

- diabetesjournals.org
N Kaiser, R Nesher, MY Donath, M Fraenkel, V … - Diabetes, 2005 - Am Diabetes Assoc
Type 2 diabetes is characterized by insulin resistance and progressive ß-cell
failure. Deficient insulin secretion, with increased proportions of insulin
precursor molecules, is a common feature of type 2 diabetes; this could ...
Cited by 26 - Related articles - BL Direct - All 6 versions

The impact of the mTOR inhibitor sirolimus on the proliferation and function of pancreatic …


CT Bussiere, JRT Lakey, AMJ Shapiro, GS … - Diabetologia, 2006 - Springer
Abstract Aims/hypothesis The Edmonton Protocol for islet trans- plantation has
provided hope for type 1 diabetic patients. However, this protocol requires
lifelong immunosuppres- sion, specifically sirolimus, a cellular ...
Cited by 29 - Related articles - BL Direct - All 4 versions

Biphasic Response of Pancreatic {beta}-Cell Mass to Ablation of Tuberous Sclerosis …

- nih.gov
Y Shigeyama, T Kobayashi, Y Kido, N … - Molecular and Cellular Biology, 2008 - Am Soc Microbiol
Recent studies have demonstrated the importance of insulin or insulin-like
growth factor 1 (IGF-1) for regulation of pancreatic β-cell mass. Given the
role of tuberous sclerosis complex 2 (TSC2) as an upstream molecule of mTOR ...
Cited by 9 - Related articles - BL Direct - All 7 versions

Insulin receptor substrate-2 proteasomal degradation mediated by a mammalian target of …


I Briaud, LM Dickson, MK Lingohr, JF … - Journal of Biological Chemistry, 2005 - ASBMB
Regulation of insulin receptor substrate (IRS)-2 expression is critical to
β-cell survival, but the mechanisms that control this are complex and
undefined. Here in pancreatic β-cells (INS-1), chronic exposure (>8 h) to ...
Cited by 44 - Related articles - All 5 versions

[CITATION] Immunotherapy with antibodies to protect beta cells in type I diabetic pancreas transplant …


P Van de Linde, P van de Boog, OMH Tysma … - Clin Exp Immunol, 2007
Cited by 2 - Related articles

[CITATION] AKT inhibitor GSK690693: Preliminary results from the first time in human study


PM LoRusso, HI Hurwitz, EG Chiorean… - Proc 99th Annu Meet AACR, 2008
Cited by 2 - Related articles


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google